Serum levels of S100B from jugular bulb as a biomarker of poor prognosis in patients with severe acute brain injury

Regional protein S100B determinations are higher than systemic determinations, thus confirming the cerebral origin of protein S100B. The transcranial protein S100B gradient is correlated to the development of brain death.